TMEM243: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: TMEM243

NCBI ID: G79161

TMEM243

TMEM243: A Potential Drug Target Or Biomarker for Various Diseases

TMEM243, also known as Chromosome 7 open reading frame 23, is a gene that has been identified as a potential drug target or biomarker for a variety of diseases. Its unique genetic structure and location on the chromosome make it an attractive target for researchers looking for new treatments.

TMEM243 is located on Chromosome 7, which is one of the largest chromosomes in the human genome. It is encoded by a protein, which is involved in a variety of cellular processes, including cell adhesion, migration, and invasion. TMEM243 has also been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the reasons why TMEM243 has generated so much interest is its location on the chromosome. Because it is located near the centromere, which is the region of the chromosome that controls the proper separation of chromosomes during cell division, researchers have found that changes in TMEM243 have been associated with defects in chromosomal stability and copy number. These changes can lead to the development of various genetic disorders, including Down syndrome, which is caused by a decrease in the number of copies of the 21st chromosome.

In addition to its location on the chromosome, TMEM243 has also been shown to be involved in the regulation of cellular processes that are important for disease development. For example, studies have shown that TMEM243 plays a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This is because it is involved in the production of a protein that is involved in the formation of neurotransmitters, which are important for the functioning of nerve cells.

Another potential reason why TMEM243 has been identified as a drug target is its role in the regulation of cellular signaling pathways. Studies have shown that TMEM243 is involved in a variety of signaling pathways that are important for cell growth, survival, and angiogenesis. This is because it is involved in the production of a protein that is involved in the regulation of cell signaling pathways, including the TGF-β pathway.

In addition to its role in cellular signaling pathways, TMEM243 has also been shown to be involved in the regulation of gene expression. This is because it is involved in the production of a protein that is involved in the regulation of gene expression, including the p53 gene. The p53 gene is a well-known gene that is involved in the regulation of cell growth and apoptosis, and studies have shown that TMEM243 is involved in the regulation of p53 gene expression.

Overall, TMEM243 is a gene that has generated a lot of interest due to its unique genetic structure and location on the chromosome. Its involvement in the regulation of cellular processes that are important for disease development, as well as its involvement in cellular signaling pathways and gene expression, make it an attractive target for researchers looking for new treatments. As more research is conducted on TMEM243, it is likely that new insights into its role in disease will emerge.

Protein Name: Transmembrane Protein 243

The "TMEM243 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM243 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets